NCT07579884: To Evaluate the Safety and Efficacy of RP902 Tablets
- State
- Under way
- Phase
- Phase 2
- People
- 360 planned
- Started
- 14 Jul 2026
- Primary completion
- May 2029
- Arms
- RP902 low dose group, RP902 high dose group
- Results
- None posted
- 12 May 2026: Trial registered
- 14 Jul 2026: Trial started